Back to search
FDAFDA · Food and drugs·Recall number D-0249-2025

Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901. Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. NDC 63304-452-01

Published March 12, 2025 · Recall initiated: February 6, 2025

Summary

FDA records drug Class II recall D-0249-2025, published March 12, 2025 and initiated February 6, 2025. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Ongoing; Reported quantity: 9840 bottles; Lot: Lot #: AD16615, Exp. Date 07/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if MORPHINE SULFATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MORPHINE SULFATE
Manufacturer
SUN PHARMACEUTICAL INDUSTRIES INC
Distributor
Nationwide within in the USA.
UPC
0363304453010
Lot
Lot #: AD16615, Exp. Date 07/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901. Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. NDC 63304-452-01 recalled?

Yes. FDA published recall D-0249-2025 on March 12, 2025. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MORPHINE SULFATE. UPC: 0363304453010.